This discussion provides an overview of nanoString technology, as an innovative advancement in digital gene expression analysis. The unique features of this technology include enzyme-free digital gene expression analysis, a dual probe hybridization process, and digital analysis to provide accurate and quantitative measurement of RNA levels. This technology offers advantages over more common methods like qPCR and RNAseq, which will be detailed in the presentation. After imparting an understanding of the capabilities and advantages of the platform, the focus shifts to address many of the criteria and challenges considered in the process of its adoption by our laboratory. Subsequently, the narrative delves into how our laboratory is actively addressing these challenges to maximize the benefits of utilizing this technology to satisfy our clients' clinical testing needs and help advance their biopharmaceutical research.